Human Papillomavirus type-16 variants in Quechua aboriginals from Argentina

Journal of Medical Virology

Volumn 69, Issue 4, 2003, Pages 546-552

  Picconi, María Alejandra ^a,e   Alonio, Lidia Virginia ^a   Sichero, Laura ^b   Mbayed, Viviana ^c   Villa, Luisa Lina ^b   Gronda, Jorge ^d   Campos, Rodolfo ^c   Teyssié, Angélica ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d Centro de Estudios Ginecologicos   (Argentina)

^e NONE   (Argentina)

Author keywords

Cervical lesions; DNA sequencing; HPV 16 phylogeny; HPV 16 variability; Hybridization; PCR

Indexed keywords

ABORIGINE; ARGENTINA; ARTICLE; ASIAN AMERICAN; CANCER GRADING; CANCER INVASION; CARCINOMA IN SITU; COLPOSCOPY; EUROPE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INDIAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEQUENCE ANALYSIS; SPAIN; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS TYPING; WART VIRUS;

ARGENTINA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; INDIANS, SOUTH AMERICAN; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS); VIRAL PROTEINS;

ARGENTINA (FISH); HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0037400107     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10343     Document Type: Article

References (53)

1. Andersson S, Alemi M, Rylander E, Strand A, Larsson B, Sällström J, Wilander E. 2000. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer 83:307-310.
2. Bernard HU, Chan S-Y, Delius H. 1994a. Evolution of Papillomaviruses. Curr Top Microbiol Immunol 186:33-53.
3. Bernard HU, Chan S-Y, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CH. 1994b. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogentic algorithms. J Inf Dis 170:1077-1085.
4. Bontkes HT, van Duin M, de Gruij ITD, Duggan-Keen MF, Walboomers JMM, Stukart MJ, Vertheijen RHM, Helmorhorst TJM, Meijer CJLM, Scheper RJ, Stevens FRA, Dyer PA, Sinnott P, Stern PL. 1998. HPV 16 infection and progression of cervical intraepithelial neoplasia: analysis of HLA polymorphism and HPV 16 sequence variants. Int J Cancer 78:166-171.
5. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Shah KV, International Biological Study on Cervical Cancer (IBSCC) Study Group. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87:796-802.
6. Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
7. Breitburd F, Coursaget P. 1999. Human papillomavirus vaccines. Seminars in Cancer Biol 9:431-445.
8. Chan S-Y, Ho L, Ong Ch-K, Chow V, Drescher B, Drüst M, ter Meulen J, Villa LL, Luande J, Mgaya H, Bernard H-U. 1992. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 66:2057-2066.
9. Cheng G, Icenogle JP, Kirnbauer R, Hubbert NL, St. Louis ME, Han CL, Svare EI, Kjaer SK, Lowy DR, Schiller JT. 1995. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J Infect Dis 172:1584-1587.
10. de Roda Husman A-M, Walboomers JMM, van den Brule AJC, Meijer CJL, Snijders PJF. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062.
11. de Villiers EM. 1994. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 186:1-12.
12. Ellis JRM, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, Hopkins D, Duggan-Keen MF, Bartholomew JS, Young LS, Stern PL. 1995. The association ofan HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nature Med 1:464-470.
13. Etherington IJ, Ellis JR, Luesley DM, Moffitt DD, Young LS. 1999. Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol Oncol 72:56-59.
14. Felsenstein J. 1993. PHYLIP: phylogeny inference package (version 3.5c). Department of Genetics, University of Washington, Seattle.
15. Hildesheim A. 1997. Human papillomavirus variants: implications for natural history studies and vaccine development efforts. J Natl Cancer Inst 89:752-753.
16. Hildesheim A, Schiffman M, Bromley Ch, Wacholder S, Herrero R, Rodriguez AC, Bratti MC, Sherman M, Scarpidis U, Lin Q-Q, Terai M, Bromley R, Buetow K, Apple R, Burk R. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318.
17. Ho L, Chan S-Y, Chow V, Chong T, Tay S-K, Villa LL, Bernard H-U. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of phylogenetic tree. J Clin Microbiol 29:1765-1772.
18. Ho L, Chan S-Y, Burk RD, Das BC, Fujinaga K, Icenogle J, Khan T, Kiviat N, Lancaster W, Mavromara-Nazos P, Labropoulou V, Mitrani-Rosenbaum S, Norrild B, Radhakrishna Pillai M, Stoerker J, Syrjänen K, Syrjänen S, Tay S-K, Villa LL, Wheeler CM, Williamson A-L, Bernard H-U. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67:6413-6423.
19. Icenogle JP, Sathya P, Miller DL, Tucker RA, Rawls WE. 1991. Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and 16. Virology 184:101-107.
20. Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H. 2000. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 81:1975-1981.
21. Kämmer C, Tommasino M, Syrjanen S, Delius H, Hebling U, Warthorst U, Pfister H, Zehbe L. 2002. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br J Cancer 86:269-273.
22. Lizano M, García Carrancá A. 1997. Las variantes moleculares de papiloma virus humanos tipo 16, 18 y 45 en tumores del cuello uterino, en México. Gac Med Mex 133:43-48.
23. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. 1996. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 69:364-368.
24. Maniatis T, Fritsch E, Sambrook J. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
25. May M, Dong X-P, Beyer-Finkler E, Stubenrauch F, Fuchs PG, Pfister H. 1994. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutations of target sequences for YY1. EMBO J 13:1460-1466.
26. Nindl I, Rindfleisch K, Lotz B, Schneider A, Dürst M. 1999. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 82:203-207.
27. O'Connor MJ, Tan SH, Tan CH, Bernard H-U. 1996. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol 70:6529-6539.
28. Pan American Health Organization (PAHO). 1996. Cancer of the uterine cervix. Bulletin of the PAHO (special issue). Vol 30.
29. Park JS, Hwang ES, Lee CJ, Kim CJ, Rha JG, Kim SJ, Namkoong SE, Um SJ. 1999. Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia. Gynecol Oncol 74:23-29.
30. Picconi MA, Alonio LV, García Carrancá A, Lizano M, Cervantes Vázquez G, Distéfano A, Mural J, Bazán G, Teyssié AR. 2000. Molecular variants ofhuman papillomavirus (HPV) types 16 and 18 in adenocarcinomas of the cervix. Medicina (Buenos Aires) 60:889-894.
31. Picconi MA, Gronda J, Alonio LV, Villa LL, Sichero L, Miranda S, Bárcena M, Teyssié AR. 2002. Human papillomavirus (HPV) in Quechua women from Jujuy, with high frequency of cancer of the cervix: viral types and HPV-16 variants. Medicina (Buenos Aires) 62:209-220.
32. Programa Nacional de Estadísticas de Salud. Estadísticas vitales. 2000. Ministerio de Salud de la Nación. Serie 5, Number 43.
33. Robles S. 2002. Cervical cancer: fighting a leading killer in the Americas. Pan American Health Organization. Non-Communicable Diseases Program. http:/www.paho.org.
34. Saiki RK, Gelfand DH, Stoffel S, Higuchi H, Horn GT, Mullís KB, Erlich HA. 1988. Primed-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-497.
35. Song YS, Kee SH, Kim JW, Park NH, Kang SB, Chang WH, Lee HP. 1997. Major sequence variants in E7 gene ofhuman papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol Oncol 66:275-262.
36. Stephen AL, Thompson CH, Tattersall MH, Cossart YE, Rose BR. 2000. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from Central China. Int J Cancer 86:695-701.
37. Stoppler MC, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. 1996. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol 70:6987-6993.
38. Tonon SA, Picconi MA, Zinovich JB, Liotta DJ, Bos P, Galuppo JA, Alonio LV, Ferreras JA, Teyssié AR. 1999. Human Papillomavirus cervical infection and associated risk factors in a region of Argentina with high incidence of cervical carcinoma. Inf Dis Obstet Gynecol 7:237-243.
39. Veress G, Szarka K, Dong X-P, Gergely L, Pfister H. 1999. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 80:1035-1043.
40. Veress G, Murvai M, Szarka K, Juhasz A, Konya J, Gergely L. 2001. Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. Eur J Cancer 37:1946-1952.
41. Villa LL, Rahal P, Franco EL. 1997. Molecular variants analysis as a tool in natural history studies of human papillomavirus infection and cervical neoplasia. In: Franco EL, Monsonego J, editors. New developments in cervical cancer screening and prevention. London: Blackwell Science, Ltd. p 379-385.
42. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. 2000. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81:2959-2968.
43. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. 1999. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12-19.
44. Wheeler CM, Yamada T, Hildesheim A, Jenison SA. 1997. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35:11-19.
45. World Health Organization. 1999. The current status of development of prophylactic vaccines against human papillomavirus infection. Report of a technical meeting, Geneva.
46. Wright DK, Manos MM. 1990. Sample preparation from paraffin-embedded tissues. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego: Academic Press, Inc. Harcourt Brace Jovanovich. p 153-158.
47. Xi LF, Koutsky LA, Galloway DA, Kruypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802.
48. Xi LF, Carter JJ, Galloway DA, Kuypers J, Hughes JP, Lee SK, Adam DE, Kiviat NB, Koutsky LA. 2002. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11:343-345.
49. Yamada T, Wheeler CM, Halpern AL, Stewart A-Ch, Hildesheim A, Jenison SA. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2 and L1 coding segments. J Virol 69:7743-7753.
50. Yamada T, Manos MM, Peto J, Greer CE, Muñoz N, Bosch FX, Wheeler CM. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71:2463-2472.
51. Zehbe I, Tommasino M. 1999. The biological significance of human papillomavirus type 16 variants for the development of cervical cancer. Papillomavirus Rep 10:105-116.
52. Zehbe I, Wilander E, Delius H, Tommasino M. 1998. Human papillomavirus 16 E6 variants are more prevalent in invasive carcinoma than the prototype. Cancer Res 58:829-833.
53. zur Hausen H. 1996. Papillomavirus infection - a major cause of human cancers. Biochim Biophys Acta 1288:F55-F78.